Airway FABP4 is decreased in COPD patients with airway bacterial infection
L. Perea (Barcelona, Spain), A. Rodrigo-Troyano (Barcelona, Spain), E. Cantó (Barcelona, Spain), M. Domínguez-Álvarez (Barcelona, Spain), J. Giner (Barcelona, Spain), F. Sánchez-Reus (Barcelona, Spain), A. Torrego (Barcelona, Spain), J. Villar-García (Barcelona, Spain), S. Quero (Barcelona, Spain), M. Garcia (Barcelona, Spain), E. Monsó (Barcelona, Spain), R. Faner (Barcelona, Spain), A. Agustí (Barcelona, Spain), S. Vidal (Barcelona, Spain), O. Sibila (Barcelona, Spain)
|  |
Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease
L. Lopez Lopez (Granada, Spain), A. Conde Valero (Granada, Spain), G. Jiménez Lozano (Granada, Spain), M. Granados Santiago (Granada, Spain), R. Romero Fernández (Granada, Spain), M. Valenza (Granada, Spain)
| |
Characterization of viral infections in stable and exacerbated COPD
D. Stolz (Basel, Switzerland), E. Papakonstantinou (Basel, Switzerland), L. Grize (Basel, Switzerland), D. Schilter (Bern, Switzerland), W. Strobel (Basel, Switzerland), R. Louis (liege, Belgium), C. Schindler (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland)
| |
Effectiveness of a smoking reduction intervention programme for smoking parents of paediatric patients in Hong Kong
S. Dai (Hong Kong, Hong Kong), K. Chan (Hong Kong, Hong Kong)
|  |
Psychiatrists as a barrier for psychiatric patients to quit smoking
Z. Barmparessou (Athens, Greece), A. Korkontzelou (Athens, Greece), M. Andritsou (Athens, Greece), K. Gkriniouk (Athens, Greece), E. Mpiniari (Athens, Greece), P. Zaharatos (Athens, Greece), D. Fotopoulos (Rethymnon, Greece), P. Katsaounou (Athens, Greece)
| |
AXIETY AND DEPPRESION IN SMOKING CESSATION CLINICS
E. Cabrera Cesar (Malaga, Spain), C. Rabade Castedo (La Coruña, Spain), C. Amado Diago (Santander, Spain), J. De Granda Orive (Madrid, Spain), F. Fiorentino (Mallorca, Spain), C. Matesanz Ruiz (Madrid, Spain), E. De Higes Martinez (Madrid, Spain)
| |
Impact of the economic crisis on the Portuguese smoking behavior
A. Fonseca Carriço (Guarda, Portugal), F. Fernandes (Guarda, Portugal), M. Oliveira (Guarda, Portugal), G. Samouco (Guarda, Portugal), R. Natal (Guarda, Portugal), J. Costa (Guarda, Portugal), F. Luís (Guarda, Portugal), L. Ferreira (Guarda, Portugal)
| |
The increased urinary polycyclic aromatic hydrocarbons (PAH) are associated with chronic obstructive pulmonary disease (COPD) in Dusty Area Cohort of South Korea.
D. Moon (Chuncheon, Republic of Korea), S. Kwon (Chuncheon, Republic of Korea), J. Heo (Chuncheon, Republic of Korea), W. Kim (Chuncheon, Republic of Korea), S. Han (Chuncheon, Republic of Korea)
| |
Airways inflammation in healthy individuals induced by traffic pollution can be sensed by fractional exhaled breath temperature (fEBT)
I. Huljev Šipoš (Šibenik, Croatia), M. Labor (Osijek, Croatia), T. Gojevic (Zagreb, Croatia), D. Plavec (Zagreb, Croatia)
| |
Identification of the major contributing sources to ambient PM2.5 oxidative potential in Athens, Greece
S. Taghvaee (Los Angeles, United States of America), M. Sowlat (Los Angeles, United States of America), E. Diapouli (Attiki, Greece), M. Manousakas (Attiki, Greece), V. Vasilatou (Attiki, Greece), K. Eleftheriadis (Attiki, Greece), C. Sioutas (Los Angeles, United States of America)
| |
Evaluation of respiratory symptoms and lung function in adolescents living in a ceramic industrial park zone
R. Mizutani (São Paulo, SP, Brazil), M. Terra-Filho (São Paulo, SP, Brazil), T. Nery (São Paulo, SP, Brazil), C. Lopes (São Paulo, SP, Brazil), R. Arbex (Araraquara, SP, Brazil), M. Arbex (Araraquara, SP, Brazil), R. Stelmach (São Paulo, SP, Brazil), U. Santos (São Paulo, SP, Brazil)
| |
Mitigating the health effects of Desert Dust Storms through exposure reduction approaches: The LIFE MEDEA Asthma study.
P. Kouis (Nicosia, Cyprus), E. Michailidi (Heraklion, Greece), S. Papatheodorou (Boston, United States of America), M. Kakkoura (Nicosia, Cyprus), E. Dimitriou (Heraklion, Greece), P. Koutrakis (Boston, United States of America), E. Galanakis (Heraklion, Greece), P. Yiallouros (Nicosia, Cyprus)
| |
Small airways effects of exposure to wood smoke
A. Muala (Umeå, Sweden), R. Österdahl (Umeå, Sweden), M. Sehlstedt (Umeå, Sweden), G. Rankin (Umeå, Sweden), J. Pourazar (Umeå, Sweden), J. Bosson (Umeå, Sweden), C. Boman (Umeå, Sweden), R. Lindgren (Umeå, Sweden), N. Garcia Lopez (Umeå, Sweden), A. Behndig (Umeå, Sweden), A. Blomberg (Umeå, Sweden), T. Sandström (Umeå, Sweden), F. Öhberg (Umeå, Sweden)
| |
Wood smoke exposure induces the activation of bronchoalveolar lavage lymphocytes
M. Sehlstedt (Umeå, Sweden), A. Muala (Umeå, Sweden), J. Pourazar (Umeå, Sweden), G. Rankin (Umeå, Sweden), O. Uski (Umeå, Sweden), A. Behndig (Umeå, Sweden), C. Boman (Umeå, Sweden), N. Garcia Lopez (Umeå, Sweden), R. Lindgren (Umeå, Sweden), T. Sandström (Umeå, Sweden), A. Blomberg (Umeå, Sweden)
| |
The role of the innate immune system in a mouse model of chemical-induced asthma
J. Vanoirbeek (Leuven, Belgium), L. Pollaris (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), A. Jonckheere (Leuven, Belgium), H. Tsui (Leuven, Belgium), G. Vande Velde (Leuven, Belgium), B. Nemery (Leuven, Belgium), P. Hoet (Leuven, Belgium)
| |
Occupational asthma audit criteria - do they meet the needs of UK specialist clinicians?
C. Barber (Sheffield, United Kingdom), D. Fishwick (Sheffield, United Kingdom)
| |
Observational study of adult patients with uncontrolled asthma in pneumology outpatients clinics in Slovenia
S. Kajba (Celje, Slovenia)
| |
Spirometric features in non-smoking women exposed to wood smoke
S. Mokaddem Mohsen (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), K. Ayed (Ariana, Tunisia), I. Hadj Khelifa (Ariana, Tunisia), N. Oueslati (Ariana, Tunisia), S. Ben Khamsa Jameleddine (Ariana, Tunisia)
| |
London-wide variation in ambulance activity for paediatric asthma
D. Razon (London, United Kingdom), I. Wolfe (London, United Kingdom), R. Iles (London, United Kingdom), J. Nevett (London, United Kingdom), K. Pike (London, United Kingdom)
| |
Asthma is associated with frailty: the GAZEL cohort
B. Landré (Villejuif, France), R. Nadif (Villejuif, France), M. Goldberg (Villejuif, France), M. Zins (Villejuif, France), J. Ankri (Villejuif, France), M. Herr (Villejuif, France)
| |
The course of asthma in preschool children with asthma
O. Oluwole (Saskatoon, Canada), D. Rennie (Saskatoon, Canada), D. Goodridge (Saskatoon, Canada), T. Litzenberger (Saskatoon, Canada), L. Chu (Saskatoon, Canada), U. Khanam (Saskatoon, Canada), J. Lawson (Saskatoon, Canada)
| |
Impact of asthma diagnosis during pregnancy on perinatal outcomes
C. Longo (Montreal, Canada), M. Schnitzer (Montreal, Canada), A. Forget (Montreal, Canada), L. Blais (Montreal, Canada)
| |
Asthma is still a risk factor for mortality in Sweden and Norway – the Nordic EpiLung Study
H. Backman (Umeå, Sweden), L. Bhatta (Trondheim, Norway), L. Hedman (Umeå, Sweden), B. Brumpton (Trondheim, Norway), I. Vähätalo (Seinäjoki, Finland), P. Lassman-Klee (Helsinki, Finland), B. Nwaru (Gothenburg, Sweden), X. Mai (Trondheim, Norway), S. Vikjord (Levanger, Norway), A. Lindberg (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden), A. Langhammer (Levanger, Norway)
| |
Respiratory health services use among children and adolescents in Ontario, Canada: A population-based study of trends from 2006-2016
I. Fong (Toronto, Canada), R. Mcgihon (Toronto, Canada), E. Terebessy (Toronto, Canada), J. Liang (Toronto, Canada), J. Zhu (Toronto, Canada), T. To (Toronto, Canada)
| |
Seasonal influenza vaccination in Canadian adolescents with and without asthma.
Y. Chen (Ottawa, Canada), X. Mai (Trondheim, Norway)
| |
Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
M. Aiello (Parma, Italy), A. Fantin (Parma, Italy), A. Frizzelli (Parma, Italy), C. Longo (Parma, Italy), M. Negri (Parma, Italy), F. Bonatti (Parma, Italy), A. Percesepe (Parma, Italy), G. Bertorelli (Parma, Italy), E. Crisafulli (Parma, Italy), I. Ferrarotti (Pavia, Italy), R. Pisi (Parma, Italy), A. Chetta (Parma, Italy)
| |
Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine)
| |
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission
M. Smirnova-Saprytskaya (??????, Russian Federation), G. Osipova (??????, Russian Federation), T. Ospelnikova (??????, Russian Federation), G. Danilina (??????, Russian Federation), K. Zykov (??????, Russian Federation)
| |
Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index
S. Korn (Mainz, Germany), W. Busse (Madison, United States of America), J. Echave-Sustaeta (Madrid, Spain), A. Dixon (Burlington, United States of America), J. Mucsi (Gödöllö, Hungary), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), N. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
| |
The German Severe Asthma Registry and Type 2-high and Type 2-low asthma phenotypes
S. Korn (Mainz, Germany), A. Koch (Friedberg, Germany), C. Schulz (Regensburg, Germany), M. Gappa (Wesel, Germany), H. Timmermann (Hamburg, Germany), R. Ehmann (Stuttgart, Germany), M. Schuhmann (Heidelberg, Germany), E. Hamelmann (Bielefeld, Germany), R. Buhl (Mainz, Germany)
| |
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
L. Frøssing (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
Analysis of psychological variables – depression levels, anxiety and mood traits - in patients with asthma, chronic urticaria and Hymenoptera venom allergy
G. Kardas (Lodz, Poland), A. Daszynska-Kardas (Lodz, Poland), M. Ambrozewicz (Lodz, Poland), A. Gabryelska (Lodz, Poland), R. Wujcik (Warsaw, Poland), P. Kuna (Lodz, Poland), M. Panek (Lodz, Poland)
| |
Fertility treatment among asthmatic women with life births – Associated with perennial allergy?
C. Tidemandsen (Copenhagen, Denmark), A. Hansen (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), E. Gade (Copenhagen, Denmark), Z. Ali (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark)
| |
Lack of association between asthma, atopy and helminthic infection in school-age children in the province of Bengo, Angola
M. Lopes Teixeira Arrais (Luanda, Angola), O. Sachicola (Luanda, Angola), F. Quifica (Luanda, Angola), J. Gama (Covilhã, Portugal), L. Taborda-Barata (Covilhã, Portugal), M. Brito (Lisboa, Portugal)
| |
The level of exhaled nitric oxide in the inhabitants in the Arctic zone of Western Siberia
A. Lobanov (Nadym, Russian Federation), S. Andronov (Nadym, Russian Federation), A. Emelyanov (St. Petersburg, Russian Federation), A. Popov (Nadym, Russian Federation), L. Lobanova (Nadym, Russian Federation), R. Kochkin (Nadym, Russian Federation), E. Bogdanova (Severodvinsk, Russian Federation), I. Protasova (Nadym, Russian Federation)
| |
Polymorphisms of IL17A/F in Siberian children with different severe asthma
S. Smirnova (Krasnoyarsk, Russian Federation), M. Smolnikova (Krasnoyarsk, Russian Federation), S. Tereshchenko (Krasnoyarsk, Russian Federation)
| |
Prevalence of food allergies and the quality of life in Korea: finding from the Korea National Health and Nutriotion Examination Survey
S. Yoon (Seoul, Republic of Korea), I. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), B. Choi (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea)
| |
Protocol to identify potential severe asthma in UK primary care
H. Heatley (Cambridge, United Kingdom), L. Bulathsinhala (Cambridge, United Kingdom), V. Carter (Cambridge, United Kingdom), I. Chaudhry (Cambridge, United Kingdom), N. Hosseini (Cambridge, United Kingdom), R. Murray (Cambridge, United Kingdom), S. Bosnic-Anticevich (Glebe, NSW, Australia), L. Heaney (Belfast, United Kingdom), D. Jackson (London, United Kingdom), R. Jones (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), P. Pfeffer (London, United Kingdom), J. Busby (Belfast, United Kingdom), A. Kaplan (Toronto, ON, Canada), E. Van Ganse (Lyon, France), M. Belhassen (Lyon, France), C. Rhee (Seoul, Republic of Korea), D. Ryan (Edinburgh, United Kingdom), A. Bourdin (Montpellier Cedex, France), P. Gibson (Newcastle, Australia), T. Tran (Gaithersburg, MD, United States of America), J. Fitzgerald (Vancouver, Canada), M. Al-Aahmad (Kuwait, Kuwait), V. Backer (Copenhagen, Denmark), D. Price (Cambridge, United Kingdom)
| |
COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection
M. Zambrano Chacon (Madrid, Spain), L. Esteban-Lucía (Madrid, Spain), C. García Talavera (Madrid, Spain), L. Nieto Roca (Madrid, Spain), A. Venegas Rodríguez (Madrid, Spain), R. Fernández Roblas (Madrid, Spain), A. Pello Lázaro (Madrid, Spain), Á. Aceña Navarro (Madrid, Spain), F. Villar Álvarez (Madrid, Spain)
| |
The comparative characteristic of indicators of cardiointervalogram, ergoreflex and 6-MWT in patients with COPD
I. Ponomareva (Ryazan, Russian Federation), V. Abrosimov (Ryazan, Russian Federation), A. Kosyakov (Ryazan, Russian Federation), A. Shakhanov (Ryazan, Russian Federation)
| |
Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD
P. Mariscal Aguilar (Madrid, Spain), R. Galera Martínez (Madrid, Spain), R. Casitas Mateo (Madrid, Spain), E. Martínez Cerón (Madrid, Spain), D. Laorden Escudero (Madrid, Spain), J. Tenes Mayen (Madrid, Spain), G. González Pozo (Madrid, Spain), F. García Río (Madrid, Spain)
| |
Impulse oscillometry in adults with severe asthma
L. Carreto (Amadora, Portugal), M. Silveira (Amadora, Portugal), M. Ferreira (Amadora, Portugal), C. Alves (Amadora, Portugal), H. Liberato (Amadora, Portugal), R. Melo (Amadora, Portugal), F. Rodrigues (Amadora, Portugal)
| |
ASSOCIATION BETWEEN EXHALED NITRIC OXIDE AND NASAL POLYPOSISIN SEVERE ASTHMA
M. Maniscalco (Telese , Italy), C. Calabrese (Napoli (NA), Italy), M. D'Amato (Napoli (NA), Italy), A. Molino (Napoli (NA), Italy), M. Aliani (Bari, Italy), A. De Felice (Telese, Italy), F. Ricciardolo (Torino, Italy), E. Carpagnano (Foggia, Italy)
| |
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
A. Marin-Muñiz (Badalona, Spain), C. Padró Casas (Badalona, Spain), M. Basagaña Torrento (Badalona, Spain), I. Garcia-Olive (Badalona, Spain), M. Martinez Colls (Badalona, Spain), A. Francoso Vicente (Badalona, Spain), F. Gonçalves Carvallho (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacos (Badalona, Spain), A. Roger Reig (Badalona, Spain), A. Teniente Serra (Badalona, Spain), E. Martinez Cáceres (Badalona, Spain), T. Navarro Ferrando (Badalona, Spain), C. Martinez Rivera (Badalona, Spain)
| |
Routine blood test biomarkers and their association with exacerbations in COPD
A. Nuñez (Barcelona, Spain), V. Marras (Sassari, Italy), C. Esquinas (Barcelona, Spain), M. Harlander (Ljubljiana, Slovenia), M. Turel (Ljubljiana, Slovenia), D. Lestan (Ljubljiana, Slovenia), E. Mekov (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), P. Pirina (Sassari, Italy), S. Negri (Sassari, Italy), M. Barrecheguren (Barcelona, Spain), M. Miravitlles (Barcelona, Spain)
| |
Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
M. Bartoli (Pisa, Italy), M. Roggi (Pisa, Italy), R. Vargiu (Pisa, Italy), C. Cardini (Pisa, Italy), S. Cianchetti (Pisa, Italy), M. Daniele (Pisa, Italy), G. Decusatis (Pisa, Italy), M. Micole (Pisa, Italy), B. Vagaggini (Pisa, Italy), P. Paggiaro (Pisa, Italy), A. Celi (Pisa, Italy)
| |
Use of inhaled corticoids and presence of eosinophilia in patients with COPD: TRACE Cohort
L. Carrasco Hernandez (Sevilla, Spain), F. Puig Rodriguez (Sevilla, Spain), M. Espinoza Solano (Sevilla, Spain), E. Márquez Martín (Sevilla, Spain), F. Órtega Ruiz (Sevilla, Spain), J. López-Campos (Sevilla, Spain)
| |
Oral corticosteroid prescription patterns in asthma care in Italy
T. Tran (Gaithersburg, United States of America), E. King (London, United Kingdom), R. Sarkar (Bengaluru, India), C. Nan (Cambridge, United Kingdom), A. Rubino (London, United Kingdom), C. O'Leary (London, United Kingdom), L. Belton (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
| |
Prevalence of the use of oral corticosteroids in asthma – a 3-year analysis in Germany
M. Lommatzsch (Rostock, Germany), C. Wilmer (Nürnberg, Germany), I. Schwab Sauerbeck (Nürnberg, Germany)
| |
Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)
C. Janson (Uppsala, Sweden), B. Nwaru (Lund, Sweden), L. Hasvold (Sodertalje, Sweden), F. Wicklund (Uppsala, Sweden), G. Telg (Sodetalje, Sweden), M. Ekstrom (Gothenburg, Sweden)
| |
Lung function, pharmacokinetics, and tolerability of indacaterol maleate and acetate in asthma patients
D. Miller (North Dartmouth, United States of America), J. Jauernig (Basel, Switzerland), S. Vaidya (Cambridge, United States of America), B. Ethell (Cambridge, United States of America), K. Wagner (East Hannover, United States of America), R. Radhakrishnan (Hyderabad, India), H. Tillmann (Basel, Switzerland)
| |
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects
H. Tillmann (Basel, Switzerland), S. Inoue (Tokyo, Japan), S. Vaidya (Cambridge, United States of America), Y. Sakita (Tokyo, Japan), S. Machineni (Hyderabad, India), K. Kobayashi (Tokyo, Japan), K. Furihata (Tokyo, Japan)
| |
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects
H. Tillmann (Basel, Switzerland), B. Ethell (Cambridge, United States of America), N. Abdallah (Basel, Switzerland), S. Machineni (Hyderabad, India), A. Drollmann (Basel, Switzerland), S. Last (Berlin, Germany), M. Hahn (Basel, Switzerland), R. Radhakrishnan (Hyderabad, India), S. Ignatenko (Berlin, Germany), S. Vaidya (Cambridge, United States of America)
| |
Lung function normalization with indacaterol/glycopyrronium/mometasone furoate in patients with asthma
K. Chapman (Toronto, Canada), H. Watz (Grosshansdorf, Germany), J. Beier (Wiesbaden, Germany), D. Singh (Manchester, United Kingdom), J. Hohlfeld (Hannover, Germany), Z. Diamant (Lund, Sweden), V. Scholz (Berlin, Germany), A. Sarkar (Oberhaching, Germany), I. Jones (Basel, Switzerland), R. Li (Beijing, China), P. Pinot (Basel, Switzerland), H. Tillmann (Basel, Switzerland)
| |
Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
G. d'Ancona (London, United Kingdom), L. Green (London, United Kingdom), M. Fernandes (London, United Kingdom), C. Roxas (London, United Kingdom), L. Osman (London, United Kingdom), K. Stewart-Knight (London, United Kingdom), J. Kavanagh (London, United Kingdom), A. Nanzer-Kelly (London, United Kingdom), D. Jackson (London, United Kingdom), B. Kent (London, United Kingdom)
| |
Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ?
A. Frix (Liège, Belgium), F. Schleich (Liège, Belgium), V. Paulus (Liège, Belgium), M. Henket (Liège, Belgium), F. Guissard (Liège, Belgium), R. Louis (Liège, Belgium)
| |
Efficacy and safety of Mepolizumab in a real world severe asthma cohort.
v. Mitchell (Birmingham, United Kingdom), K. Howles (Birmingham, United Kingdom), L. White (Birmingham, United Kingdom), A. Pillai (Birmingham, United Kingdom), A. Mansur (Birmingham, United Kingdom)
| |
Treatment patterns in stable COPD patients – results from a large observational European study (SPACE)
Y. Adir (Haifa, Israel), A. Horner (Linz, Austria), G. De Vries (Sittard, Netherlands), F. Mihaltan (Bucharest, Romania), Y. Chen (Shanghai, China), S. Alecu (Bucharest, Romania), L. Adamek (Luton, United Kingdom)
| |
Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results
K. Wing (London, United Kingdom), E. Williamson (London, United Kingdom), J. Carpenter (London, United Kingdom), L. Wise (London, United Kingdom), S. Schneeweiss (Boston, United States of America), L. Smeeth (London, United Kingdom), J. Quint (London, United Kingdom), I. Douglas (London, United Kingdom)
| |
Risk of bacterial infection in COPD patients with Vitamin D defficiency
R. Jha (Faridabad, India)
| |
COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study
H. Worth (Fuerth, Germany), C. Criée (Bovenden, Germany), P. Kardos (Frankfurt am Main, Germany), V. Obermoser (Nuremberg, Germany), K. Berschneider (Nuremberg, Germany), R. Buhl (Mainz, Germany), C. Vogelmeier (Marburg, Germany)
| |
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
I. Haaland (Bergen, Norway), S. Tangedal (Bergen, Norway), R. Nielsen (Bergen, Norway), M. Aanerud (Bergen, Norway), P. Bakke (Bergen, Norway), T. Eagan (Bergen, Norway)
| |
BPI-fold containing Family A member 1 (Bpifa1) Role in IFN Driven Pulmonary Response
S. Khanal (New Haven, United States of America), N. Niu (New Haven, United States of America), L. Sharma (New Haven, United States of America), W. Liu (New Haven, United States of America), L. Cohn (New Haven, United States of America), C. Dela Cruz (New haven, United States of America), C. Britto (New Haven, United States of America)
| |
The biology of COPD
J. Hogg (Vancouver (BC), Canada), A. Agusti Garcia-Navarro (Barcelona, Spain)
|   |
Low maximum inspiratory flow index in patients with inhaler therapy
W. Giron Matute (Madrid, Spain), M. Hernández Yáñez (Madrid, Spain), R. Rojas Moreno-Tomé (Madrid, Spain), M. Gallardo Bermejo (Madrid, Spain), M. Suarez Rubio (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
| |
MATERNAL CONSUMPTION OF TOBACCO AND PREGNANCY
L. Perera Lopez (MADRID, Spain), R. Solano Garcia-Tenorio (MADRID, Spain), T. Lopez Ruiz (MADRID, Spain), A. Calatrava Romero (MADRID, Spain), A. Martín Hernández (MADRID, Spain), M. Izquierdo Nazar (MADRID, Spain), J. Salamanca Blanco (MADRID, Spain), J. Vargas Espinal (MADRID, Spain), P. Vaquero Lozano (MADRID, Spain), A. Gomez Del Aguila (MADRID, Spain)
| |
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients.
L. Leal (Cabo Frio, Brazil), D. Gonçalves (Cabo Frio, Brazil), J. Azevedo (Cabo Frio, Brazil), P. Mazeika (Cabo Frio, Brazil), W. Mendonça (Cabo Frio, Brazil), F. Reis (Cabo Frio, Brazil), R. Nascimento (Cabo Frio, Brazil), Y. De Souza (Cabo Frio, Brazil)
| |
EXPIRATORY FLOW LIMITATION BY IMPULSE OSCILLOMETRY SYSTEM EVALUATION IN SEVERE OBESITY WOMEN
L. Perossi (Ribeirão Preto, Brazil), J. Perossi (Ribeirão Preto, Brazil), D. Santos (Ribeirão Preto, Brazil), M. Assunção (Ribeirão Preto, Brazil), R. Moroli (Ribeirão Preto, Brazil), W. Salgado Jr (Ribeirão Preto, Brazil), A. Gastaldi (Ribeirão Preto, Brazil)
| |
Gait speed is associated with physical activity in patients with Chronic Obstructive Pulmonary Disease
A. Tamaki (Kobe, Japan), M. Koizumi (Kobe, Japan), H. Tamura (Kobe, Japan)
| |
The effect of endoscopic lung volume reduction on functional outcomes in patients with severe emphysema.
A. Blondeel (Leuven, Belgium), C. Dooms (Leuven, Belgium), K. Denaux (Leuven, Belgium), H. Demeyer (Leuven, Belgium), T. Troosters (Leuven, Belgium), J. Coolen (Leuven, Belgium), D. Van Raemdonck (Leuven, Belgium), G. Verleden (Leuven, Belgium), W. Janssens (Leuven, Belgium)
| |
The effect of time elapsed since expectoration on sputum eosinophil differential cell counts
G. Tavernier (Manchester, United Kingdom), P. Aspin (Manchester, United Kingdom), S. Ben-Akinduro (Manchester, United Kingdom), Z. Mehmood (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom), S. J. Fowler (Manchester, United Kingdom), R. Niven (Manchester, United Kingdom)
| |
Comparison of spirometry interpretation using GLI2012 and ECSC reference values in Afro-descendants
T. Duarte (Setúbal, Portugal), A. Clérigo (Lisbon, Portugal), C. Silva (Lisbon, Portugal)
| |
Within session variability of FEV1 and FVC pre- and post-bronchodilation
B. Coupland (Birmingham, United Kingdom), J. Stockley (Birmingham, United Kingdom), B. Cooper (Birmingham, United Kingdom)
| |
Aerosol delivery through an endotracheal tube in a model of a spontaneously breathing child.
A. Berlinski (Little Rock, United States of America), M. Tucker (Little Rock, United States of America)
| |
Mechanisms of orthopnea in patients with advanced COPD
A. Elbehairy (Alexandria, Egypt), A. Faisal (Manchester, United Kingdom), H. Mcisaac (Kingston, Canada), C. Ciavaglia (Kingston, Canada), J. Neder (Kingston, Canada), D. O'Donnell (Kingston, Canada)
| |
Breathlessness during exacerbation of chronic obstructive pulmonary disease (ECOPD) and recovery
P. Cho (London, United Kingdom), H. Fletcher (London, United Kingdom), I. Patel (London, United Kingdom), G. Rafferty (London, United Kingdom), J. Moxham (London, United Kingdom), R. Turner (London, United Kingdom), S. Birring (London, United Kingdom), C. Jolley (London, United Kingdom)
| |
Modifications of aerobic performance and ventilatory responses during exercise in COPD patients undergone to lung resection
D. Campos Bedin (São Paulo, Brazil), R. Pulcheri (São Paulo, Brazil), E. Brito (São Paulo, Brazil), I. Ivanaga (São Paulo, Brazil), I. Santoro (São Paulo, Brazil), L. Nery (São Paulo, Brazil), S. Faresin (São Paulo, Brazil)
| |
Teleauscultation: an innovative initiative to categorize and analyse lung sounds
J. Tolnai (Szeged, Hungary), K. Kapus (Szeged, Hungary), M. Draskóczy (Szeged, Hungary), F. Bari (Szeged, Hungary), F. Peták (Szeged, Hungary), Z. Novák (Szeged, Hungary)
| |
Improvement of inspiratory muscle strength as an effect of complex pulmonary rehabilitation in patient with COPD.
B. Bayer (Budapest, Hungary), M. Kerti (Budapest, Hungary), K. Kelemen (Budapest, Hungary), J. Varga (Budapest, Hungary)
| |
Cognitive function improvements following three-week pulmonary rehabilitation program in COPD lung-transplant recipients
V. Andrianopoulos (Schoenau am Koenigssee, Germany), R. Gloeckl (Schoenau am Koenigssee, Germany), M. Boensch (Schoenau am Koenigssee, Germany), K. Hoster (Marburg, Germany), T. Schneeberger (Schoenau am Koenigssee, Germany), I. Jarosch (Schoenau am Koenigssee, Germany), R. Koczulla (Schoenau am Koenigssee, Germany), K. Kenn (Schoenau am Koenigssee, Germany)
| |
Non-pharmacological strategies to prevent hospitalisation in advanced stable COPD
A. Carlucci (San Donato Milanese (MI), Italy)
| |
Clinical approach to very severe asthma and changes from the previous ERS-ATS task force
J. Cardet (Tampa, United States of America)
| |
Successful Treatment of Tracheal Stenosis with Cryospray Therapy
R. Alalawi (Phoenix, United States of America)
|  |
Group assignment
B. Nemery (Leuven, Belgium), P. Cullinan (London, United Kingdom), P. Blanc (San Francisco, United States of America), M. Cruz Carmona (Barcelona, Spain)
| |
Only severe asthma?
A. Möller (Zürich, Switzerland)
| |
Severe preschool wheeze: when and how to treat
L. Bacharier (St Louis, United States of America)
| |
Patient testimony
M. Odemyr (Järved, Sweden)
No content made available | No content made available |
Global Vision of the Document on smoking cessation training for medical school
C. Jimenez Ruiz (Madrid, Spain)
| |
The clinical importance of small airway involvement in patients with asthma and COPD
M. van den Berge (Groningen, Netherlands)
| |
Difficulties in the treatment of asthma in pregnant women
M. Schatz (San Diego, United States of America)
| |
Asthma and pregnancy
R. Fassakhov (Kazan (Republic of Tatarstan), Russian Federation)
| |
Welcome and ice-breaker
No content made available | No content made available |
Typical primary care case: an asthma patient that uses his blue inhaler three times a day
D. Attar (London, United Kingdom)
| |
Cholinergic synapse pathway gene polymorphisms associated with allergen-induced late asthmatic responses
Ashwini Rajasekaran, Daniel He, Alice Yue, Amrit Singh, Casey P. Shannon, J. Mark FitzGerald, Louis-Philippe Boulet, Paul M. O'Byrne, Gail M. Gauvreau, Scott J. Tebbutt
ERJ Open Res, 5 (4) 00107-2019; 10.1183/23120541.00107-2019 |  |
Snus in pregnancy and infant birth size: a mother–child birth cohort study
Ina Kreyberg, Katarina Hilde, Karen Eline S. Bains, Kai-Håkon Carlsen, Berit Granum, Guttorm Haugen, Gunilla Hedlin, Christine M. Jonassen, Live S. Nordhagen, Björn Nordlund, Corina S. Rueegg, Katrine D. Sjøborg, Håvard O. Skjerven, Anne C. Staff, Riyas Vettukattil, Karin C. Lødrup Carlsen
ERJ Open Res, 5 (4) 00255-2019; 10.1183/23120541.00255-2019 | |
Sex differences in health services and medication use among older adults with asthma
Teresa To, Natasha Gray, Kandace Ryckman, Jingqin Zhu, Ivy Fong, Andrea Gershon
ERJ Open Res, 5 (4) 00242-2019; 10.1183/23120541.00242-2019 | |
FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals
Laurent Portel, Eric Parrat, Cécilia Nocent-Ejnaini, Gilles Mangiapan, Anne Prud'homme, Jean-Philippe Oster, Corinne Aperre de Vecchi, Cyril Maurer, Chantal Raherison, Didier Debieuvre
ERJ Open Res, 5 (4) 00069-2019; 10.1183/23120541.00069-2019 | |
Response: The most fundamental change in asthma management in 30 years?
Helen K. Reddel
Eur Respir J, 54 (5) 1901860; 10.1183/13993003.01860-2019 | |
Airway and alveolar epithelial cells in culture
Pieter S. Hiemstra, Teresa D. Tetley, Sam M. Janes
Eur Respir J, 54 (5) 1900742; 10.1183/13993003.00742-2019 | |
Airway morphometry in COPD with bronchiectasis: a view on all airway generations
Stephanie Everaerts, John E. McDonough, Stijn E. Verleden, Iván Josipovic, Matthieu Boone, Adriana Dubbeldam, Carolien Mathyssen, Jef Serré, Lieven J. Dupont, Ghislaine Gayan-Ramirez, Johny Verschakelen, James C. Hogg, Geert M. Verleden, Bart M. Vanaudenaerde, Wim Janssens
Eur Respir J, 54 (5) 1802166; 10.1183/13993003.02166-2018 | |